Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration. / Yang, Mengbi; Zhang, Qian; Wang, Qianwen; Sørensen, Kasper K.; Boesen, Josephine T.; Ma, Sum Yi; Jensen, Knud J.; Kwan, Kin Ming; Ngo, Jacky Chi Ki; Chan, Ho Yin Edwin; Zuo, Zhong.

In: Molecular Pharmaceutics, Vol. 15, No. 12, 2018, p. 5781-5792.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Yang, M, Zhang, Q, Wang, Q, Sørensen, KK, Boesen, JT, Ma, SY, Jensen, KJ, Kwan, KM, Ngo, JCK, Chan, HYE & Zuo, Z 2018, 'Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration', Molecular Pharmaceutics, vol. 15, no. 12, pp. 5781-5792. https://doi.org/10.1021/acs.molpharmaceut.8b00938

APA

Yang, M., Zhang, Q., Wang, Q., Sørensen, K. K., Boesen, J. T., Ma, S. Y., ... Zuo, Z. (2018). Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration. Molecular Pharmaceutics, 15(12), 5781-5792. https://doi.org/10.1021/acs.molpharmaceut.8b00938

Vancouver

Yang M, Zhang Q, Wang Q, Sørensen KK, Boesen JT, Ma SY et al. Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration. Molecular Pharmaceutics. 2018;15(12):5781-5792. https://doi.org/10.1021/acs.molpharmaceut.8b00938

Author

Yang, Mengbi ; Zhang, Qian ; Wang, Qianwen ; Sørensen, Kasper K. ; Boesen, Josephine T. ; Ma, Sum Yi ; Jensen, Knud J. ; Kwan, Kin Ming ; Ngo, Jacky Chi Ki ; Chan, Ho Yin Edwin ; Zuo, Zhong. / Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration. In: Molecular Pharmaceutics. 2018 ; Vol. 15, No. 12. pp. 5781-5792.

Bibtex

@article{cbc7371e63f2458d9b0f01f72f7711a5,
title = "Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration",
author = "Mengbi Yang and Qian Zhang and Qianwen Wang and S{\o}rensen, {Kasper K.} and Boesen, {Josephine T.} and Ma, {Sum Yi} and Jensen, {Knud J.} and Kwan, {Kin Ming} and Ngo, {Jacky Chi Ki} and Chan, {Ho Yin Edwin} and Zhong Zuo",
year = "2018",
doi = "10.1021/acs.molpharmaceut.8b00938",
language = "English",
volume = "15",
pages = "5781--5792",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "12",

}

RIS

TY - JOUR

T1 - Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration

AU - Yang, Mengbi

AU - Zhang, Qian

AU - Wang, Qianwen

AU - Sørensen, Kasper K.

AU - Boesen, Josephine T.

AU - Ma, Sum Yi

AU - Jensen, Knud J.

AU - Kwan, Kin Ming

AU - Ngo, Jacky Chi Ki

AU - Chan, Ho Yin Edwin

AU - Zuo, Zhong

PY - 2018

Y1 - 2018

U2 - 10.1021/acs.molpharmaceut.8b00938

DO - 10.1021/acs.molpharmaceut.8b00938

M3 - Journal article

C2 - 30392378

VL - 15

SP - 5781

EP - 5792

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 12

ER -

ID: 213159143